Verastem, Inc. (VSTM)
10.04
-0.02
(-0.20%)
USD |
NASDAQ |
Oct 23, 16:00
10.02
-0.02
(-0.20%)
After-Hours: 20:00
Verastem Total Liabilities (Quarterly) : 156.52M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 156.52M |
| March 31, 2026 | 146.03M |
| December 31, 2025 | 189.24M |
| September 30, 2025 | 192.38M |
| June 30, 2025 | 160.21M |
| March 31, 2025 | 164.13M |
| December 31, 2024 | 130.43M |
| September 30, 2024 | 94.16M |
| June 30, 2024 | 65.74M |
| March 31, 2024 | 77.32M |
| December 31, 2023 | 71.18M |
| September 30, 2023 | 71.81M |
| June 30, 2023 | 69.01M |
| March 31, 2023 | 66.69M |
| December 31, 2022 | 47.66M |
| September 30, 2022 | 48.22M |
| June 30, 2022 | 46.52M |
| March 31, 2022 | 43.38M |
| December 31, 2021 | 21.10M |
| September 30, 2021 | 16.22M |
| June 30, 2021 | 35.68M |
| March 31, 2021 | 34.29M |
| December 31, 2020 | 39.08M |
| September 30, 2020 | 88.00M |
| June 30, 2020 | 84.16M |
| Date | Value |
|---|---|
| March 31, 2020 | 85.17M |
| December 31, 2019 | 137.87M |
| September 30, 2019 | 171.08M |
| June 30, 2019 | 169.23M |
| March 31, 2019 | 154.90M |
| December 31, 2018 | 152.94M |
| September 30, 2018 | 75.54M |
| June 30, 2018 | 46.05M |
| March 31, 2018 | 29.86M |
| December 31, 2017 | 32.11M |
| September 30, 2017 | 22.15M |
| June 30, 2017 | 13.61M |
| March 31, 2017 | 15.78M |
| December 31, 2016 | 11.33M |
| September 30, 2016 | 6.608M |
| June 30, 2016 | 6.355M |
| March 31, 2016 | 6.596M |
| December 31, 2015 | 10.62M |
| September 30, 2015 | 11.42M |
| June 30, 2015 | 10.44M |
| March 31, 2015 | 10.10M |
| December 31, 2014 | 9.883M |
| September 30, 2014 | 9.072M |
| June 30, 2014 | 8.163M |
| March 31, 2014 | 6.401M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cytokinetics, Inc. | 2.098B |
| United Therapeutics Corp. | 819.80M |
| SELLAS Life Sciences Group, Inc. | 7.726M |
| AbbVie, Inc. | 141.00B |
| Dianthus Therapeutics, Inc. | 41.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 206.51M |
| Shareholders Equity (Quarterly) | 49.99M |
| Debt to Equity Ratio | 1.687 |
| Current Ratio | 2.255 |
| Net Debt Paydown Yield | -0.44% |